Sahil Dhingra
Stock Analyst at RBC Capital
(1.57)
# 3,257
Out of 4,334 analysts
2
Total ratings
50%
Success rate
-0.5%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Sahil Dhingra
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LGND Ligand Pharmaceuticals | Reiterated: Buy | $252 → $262 | $229.33 | +14.25% | 2 | May 11, 2026 |
Ligand Pharmaceuticals
May 11, 2026
Reiterated: Buy
Price Target: $252 → $262
Current: $229.33
Upside: +14.25%